Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation
Which stocks are undervalued right now? Check free
Discover now →
Barclays PLC (BCSN) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Barclays PLC MXN 480, price MXN 428, upside +12.1%, quality 63 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Fair value above price? Yes
- Good quality? Yes
- Add to watchlist
BP
Broad data
Sep 29, 2026
Barclays PLC
BCSN · MXUndervaluedThe stock appears undervalued with acceptable quality.
✓Fair value 480.18 MXN · Undervalued (+12.1%)
✓Quality 63/100
✓Healthy Growth (revenue 5y +6.2 %/yr)
✓Highly profitable · 26.8% net margin (TTM)
!High debt · generates free cash flow
✓Wide moat 66/100
What runs behind every stock
26
valuation models
8 families, DCF to NCAV
37
quality factors
margins, balance sheet, cashflow, debt
6
AI factors
moat, what no ratio measures
2,000+
data points
verified, per stock, median
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 29, 2026.
How to read this chart
60‑month range 104.80 MXN – 492.99 MXN · fair‑value band 449.15 MXN – 535.47 MXN · the 428.31 MXN price screens below the 480.18 MXN fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 29, 2026.
Company profile
Barclays PLC provides various financial services in the United Kingdom, Europe, the Americas, Africa, the Middle East, and Asia. The company operates through Barclays UK; Barclays UK Corporate Bank; Barclays Private Bank and Wealth Management; Barclays Investment Bank; and Barclays US Consumer Bank segments.
Show more
Barclays PLC provides various financial services in the United Kingdom, Europe, the Americas, Africa, the Middle East, and Asia. The company operates through Barclays UK; Barclays UK Corporate Bank; Barclays Private Bank and Wealth Management; Barclays Investment Bank; and Barclays US Consumer Bank segments. It offers financial services, such as current accounts, savings accounts, mortgages and unsecured lending, such as credit cards and loans retail banking, wholesale banking, investment banking, wealth management, and investment management services, as well as lending products. In addition, the company engages in securities dealing activities and issuing of credit cards. The company was formerly known as Barclays Bank public limited company and changed its name to Barclays PLC in January 1985. Barclays PLC was founded in 1690 and is headquartered in London, the United Kingdom.
Stock analysis
Barclays PLC (BCSN) currently trades at 428.31 MXN, while our model-based Fair Value estimate is 480.18 MXN, implying the stock looks roughly 10.8% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 664.97 MXN per share, and 3 of the 6 models we run sit above the 428.31 MXN price.
Bear case: the Dividend Discount group reads lowest at 215.80 MXN, and 3 of the 6 models stay below the price. Evidence for this calculation is high.
Scenario range: 449.15 MXN (bear) to 535.47 MXN (bull), the price of 428.31 MXN sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 63/100 (solid quality), in the Financial Services sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Barclays PLC reported revenue of £29.1B in FY2025 versus £21.9B in FY2021, a compound +7.4%/yr. Reported net income was £7.2B in FY2025, compounding +3.0%/yr from FY2021.
Key figures
Market cap 1.6T MXN (≈ $88.3B) · P/E ratio 10.7 · P/S ratio 2.62 · EPS (TTM) 40.17 MXN · Dividend yield 0.0% · Net margin 24.6% · Return on equity 9.6% · Return on assets (EBIT) 0.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades about 13% below its 52-week high and 19% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −17% fair-value upside, at 12%, BCSN screens cheaper than that median.
Fair Value models
Bear 449.15 MXN
Fair Value 480.18 MXN
Bull 535.47 MXN
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (30.31 MXN per share) are deliberately not added.
Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.
Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Residual Income
481.75 MXN
526.37 MXN
626.68 MXN
76
Gordon GGM
147.41 MXN
242.55 MXN
352.64 MXN
67
DDM Multi-Stage
147.41 MXN
215.80 MXN
292.05 MXN
67
All 6 models by family
Dividend Discount
Gordon GGM
147.41 MXN
242.55 MXN
352.64 MXN
67
DDM Multi-Stage
147.41 MXN
215.80 MXN
292.05 MXN
67
Multiples
P/E Multiple
498.73 MXN
664.97 MXN
831.21 MXN
63
P/B Multiple
582.50 MXN
776.67 MXN
970.83 MXN
55
Asset-Based
NCAV (Graham)
277.38 MXN
371.69 MXN
554.76 MXN
54
Economic Profit
Residual Income
481.75 MXN
526.37 MXN
626.68 MXN
76
Notify me when BCSN reaches fair value
Put BCSN on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Quality Score breakdown
Overall quality
63/100
Of which business quality 65 · Market factors (momentum, volatility) 62
Profitability
33
Margins and returns on capital today
Quality Growth
39
Are margins and returns improving?
Cashflow
98
Earnings quality: real cash, not paper profit
Fin. Strength
50
Balance sheet, leverage, solvency risk
Investment
83
Disciplined investing over empire-building
Low Volatility
72
Calm price path (market factor)
Momentum
56
Price trend over the last 3–12 months (market factor)
52W Momentum
62
Distance to the 52-week high (market factor)
Net Issuance
100
Share count: buybacks or dilution?
Revenue & earnings trend
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.
77/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+11.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.2%
Start year 2020 (pandemic). Over 10 years: +4.0% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.3%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+29.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+29.5%
Dividend (yield on the price)0.0%
Profit margin 2014 to 2019 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.12% → 29%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+0.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+4.8%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in GBP, UK: IMF forecast 2.3% a year to 2030, 3.3% from 2016 to 2025) that is about −1.8% a year for the price and +2.4% for the forecasts.
Forecast 2026 (sales)+6.7%
Forecast 2027 (sales)+4.9%
Projected 2028 (sales)+4.5%
Projected 2029 (sales)+4.2%
Projected 2030 (sales)+3.8%
Watch BCSN, get fair value alerts →
Recent news
News mood ⓘNews mood, the average tone of recent news (98 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.
Negative
Recent news coverage is more negative than average.
- Can U.K. Loan Growth & Tech Spending Lift Barclays' Earnings?
- Barclays staffers are demanding more money to return to the office—they want compensation for the $410 weekly cost of childcare and commutin
Compare Barclays PLC with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Context: sector, industry, market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
None of the checked exposures detected
Similar stocks
10 more Banks - Diversified stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| JPMorgan Chase & Co JPM | $330.83 | $188.11 | −43% |
| Industrial and Commercial Bank of China Limited 601398 | ¥8.28 | ¥10.93 | +32% |
| China Construction Bank Corporation 601939 | ¥10.98 | ¥13.69 | +25% |
| Bank of America Corporation BAC | $55.47 | $42.37 | −24% |
| Agricultural Bank of China Limited 601288 | ¥6.97 | ¥12.94 | +86% |
| Bank of China Limited 601988 | ¥6.62 | ¥9.86 | +49% |
| Royal Bank of Canada RY | $200.95 | $130.85 | −35% |
| Mitsubishi UFJ Financial Group MUFG | $23.37 | $14.86 | −36% |
| Wells Fargo & Company WFC | $80.05 | $66.44 | −17% |
| Citigroup Inc C | $130.80 | $107.10 | −18% |
Explore undervalued stocks
More undervalued Financial Services stocks →
All undervalued stocks
TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
🥇 Backtested Best
🏆 Big Names
⭐ Top Rated
💎 Quality on Sale
🚀 Profitable Growth
🧊 Quality Compounders
💵 Dividend Stars
📈 Strong Momentum
📉 Fallen Angels
⚖️ Deeply Undervalued
🔍 Small-Cap Gems
🏰 Moat at a Fair Price
💼 Insider Buying
🎩 Buffett-Style Quality
📚 Peter Lynch GARP
🧮 Greenblatt Magic Formula
🛡️ Graham Defensive
Discover tools
Stock screenerFilter by region, size and sector
Compare toolTwo stocks side by side
Extrinsic Value Calculator…Calculator with industry benchmark
Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
Frequently asked questions
Is Barclays PLC (BCSN) overvalued or undervalued?
As of Sep 29, 2026, our model estimates a fair value of 480.18 MXN versus the last price from Sep 24, 2026 of 428.31 MXN, about +12% upside (undervalued).
What is the fair value of BCSN?
Our model-based fair value for Barclays PLC is 480.18 MXN (as of Sep 29, 2026), built from audited fundamentals. Last price (from Sep 24, 2026): 428.31 MXN.
What is the quality score of BCSN?
Barclays PLC has a Quality Score of 63/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Barclays PLC (BCSN)?
Our model-based price target is the fair value of 480.18 MXN (as of Sep 29, 2026) from 6 valuation models. Cautious scenario 449.15 MXN, optimistic scenario 535.47 MXN. It is a calculation from audited fundamentals, not an analyst target.
What is the Barclays PLC stock forecast for 2026?
Our models put fair value at 480.18 MXN, about +12% upside versus the last price from Sep 24, 2026 of 428.31 MXN (undervalued). Cautious scenario 449.15 MXN, optimistic scenario 535.47 MXN. The calculation is refreshed regularly with new filings.
What is the revenue of Barclays PLC (BCSN)?
Barclays PLC reported trailing-twelve-month revenue of about £27.1B (latest available figure, as of Sep 29, 2026).
Does Barclays PLC pay a dividend?
Barclays PLC currently shows a dividend yield of about 0.02% relative to its recent price (as of Sep 29, 2026).
What growth is priced into Barclays PLC (BCSN)?
For today's price to be fair in a discounted-cash-flow model, Barclays PLC would have to grow free cash flow by +0.5 % per year for five years (discount rate 11.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +6.2 % per year. As of Sep 29, 2026.
What discount rate (WACC) does the fair value of BCSN use?
Our models discount Barclays PLC at 11.1 %: a base by market capitalisation (large), damped by beta 0.88, country premium for Mexico. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Barclays PLC that is +0.5 % per year a year over ten years, using the same discount rate (11.1 %) and the same formula as our fair value.
How much growth has Barclays PLC (BCSN) delivered so far?
Over the past 5 years revenue at Barclays PLC grew +6.2 % a year. The price currently implies +0.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Barclays PLC (BCSN) growing?
The median revenue growth in the sector is +9.3 % a year. That is the yardstick for the growth priced into Barclays PLC (+0.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Barclays PLC (BCSN)?
The free-cash-flow yield on the price is 6.89 %: that much free cash flow Barclays PLC produces per unit of market value. When it exceeds the discount rate of our models (11.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Barclays PLC (BCSN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Barclays PLC it is 480.18 MXN per share (as of Sep 29, 2026), against a price of 428.31 MXN. It is the blended result of 6 valuation models (cash flow, earnings, asset, dividend).
Is Barclays PLC stock overvalued or undervalued in 2026?
As of Sep 29, 2026, BCSN trades below its calculated fair value: price 428.31 MXN, fair value 480.18 MXN, a gap of about +12% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BCSN?
No. The price is what the market pays today (428.31 MXN); the fair value is what the company's own numbers justify (480.18 MXN). For Barclays PLC the two are 51.87 MXN per share apart. That gap is exactly why we show both numbers side by side.
How much is Barclays PLC worth?
The market values Barclays PLC at about 1.6T MXN (market capitalisation, as of Sep 29, 2026). Per share that is 428.31 MXN; our models calculate a fair value of 480.18 MXN per share.
What do the bullish and bearish scenarios say about BCSN?
Our models span a range for Barclays PLC: cautious scenario 449.15 MXN, base 480.18 MXN, optimistic 535.47 MXN per share (as of Sep 29, 2026, price 428.31 MXN). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is BCSN from its 52-week high?
Barclays PLC trades at 428.31 MXN, about 13% below its 52-week high of 492.99 MXN and 19% above the low of 360.77 MXN (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 480.18 MXN is for.
Which stocks are comparable to Barclays PLC?
From the same area (Financial Services) we also value JPMorgan Chase & Co, Industrial and Commercial Bank of China Limited, China Construction Bank Corporation, Bank of America Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Barclays PLC stock attractive at the current price?
The data as of Sep 29, 2026: price 428.31 MXN, calculated fair value 480.18 MXN (+12%), Quality Score 63/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BCSN calculated?
We run Barclays PLC through 6 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 480.18 MXN, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Barclays PLC currently trades 11 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Barclays PLC (BCSN)?
The latest price we hold is from Sep 24, 2026 and stands at 428.31 MXN. Our model-based fair value is 480.18 MXN, about +12% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Barclays PLC right now?
The price is below even our cautious bear case (449.15 MXN). The market is more pessimistic than our downside scenario. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Key figures of Barclays PLC
How large is the market capitalisation of Barclays PLC (BCSN)?
The market capitalisation of Barclays PLC is 1.6T MXN (≈ $88.3B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/E ratio of Barclays PLC (BCSN)?
The price-to-earnings ratio of Barclays PLC is 10.7. Price to earnings: how many years of current profit you pay for the stock. A P/E of 10 means ten years of profit.
What is the P/S ratio of Barclays PLC (BCSN)?
The price-to-sales ratio of Barclays PLC is 2.62 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Barclays PLC (BCSN)?
Earnings per share at Barclays PLC are 40.17 MXN (price ÷ EPS = P/E 10.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Barclays PLC (BCSN)?
The dividend yield of Barclays PLC is 0.0% (payout 0.2%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Barclays PLC (BCSN)?
The net margin of Barclays PLC is 24.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Barclays PLC (BCSN)?
The return on equity (ROE) of Barclays PLC is 9.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Barclays PLC (BCSN)?
On an EBIT basis the return on assets of Barclays PLC is 0.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Barclays PLC (BCSN)?
The operating margin of Barclays PLC is 39.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Barclays PLC (BCSN)?
Revenue at Barclays PLC is growing +3.9% versus a year earlier (3y avg +5.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Barclays PLC (BCSN)?
Earnings per share at Barclays PLC are growing +8.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Barclays PLC (BCSN) carry?
The net debt of Barclays PLC is £17.6B (fiscal year 2019, ≈ 1.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Continue in the live analysis
Fair value and trend for 35,000+ stocks, watchlist, comparison and the diversification check. You can also try 14 days of Pro there, no card.
Open the live analysis →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.